GGrantIndex
Sort

23,748 grants matching melanoma

Deciphering MDSC function for GBM targeting

$217,469
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NS

Tracking Cellular Migration In Vivo

$217,448
Dario Aa Vignali · St. Jude Children'S Research Hospital · R21 · FY2011 · AI

Effect of GM-CSF And Vaccine Site Number On Immunization With Melanoma Peptides

$217,441
University Of Virginia Charlottesville · M01 · FY2004 · RR

RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION

$217,440
Marshall University · R01 · FY2003 · CA

RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION

$217,440
Marshall University · R01 · FY2004 · CA

RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION

$217,440
Marshall University · R01 · FY2001 · CA

RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION

$217,440
Marshall University · R01 · FY2002 · CA

Regulatory Role of Mitochondrial DNA in Bladder Cancer Progression

$217,388
John A Taylor · University Of Kansas Medical Center · R21 · FY2023 · CA

IMMUNOSUPPRESSIVE NEUROBLASTOMA TUMOR GANGLIOSIDES

$217,349
Children'S Research Institute · R01 · FY2000 · CA

CORE--NFORMATICS, TISSUE RESOURCE, AND PATHOLOGY

$217,315
University Of Texas Md Anderson Can Ctr · P50 · FY2004 · CA

CORE--NFORMATICS, TISSUE RESOURCE, AND PATHOLOGY

$217,315
Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2006 · CA

CORE--NFORMATICS, TISSUE RESOURCE, AND PATHOLOGY

$217,315
University Of Texas Md Anderson Can Ctr · P50 · FY2005 · CA

Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling

$217,303
Samir S Mitragotri · University Of California Santa Barbara · R21 · FY2016 · CA

Collaborative Systems for Analyzing Tissue Microarrays

$217,284
David J Foran · Rbhs-Robert Wood Johnson Medical School · R01 · FY2014 · CA

Metabolic Drivers of Melanoma Initiation, Progression and Therapy Response

$217,283
Narendra Wajapeyee · Yale University · R21 · FY2015 · CA

Molecular Imaging of Novel Immuno-therapy and Targeted Therapies for Malignant...

$217,272
Antoni Ribas · University Of California Los Angeles · P50 · FY2014 · CA

Flow Cytometry Core

$217,268
Fumito Ito · University Of Southern California · P30 · FY2025 · CA

Targeting COPZl in miR-152 deficient tumor cells

$217,202
Michael Shtutman · University Of South Carolina At Columbia · P20 · FY2017 · GM

Southwest Oncology Group

$217,197
Lawrence E Flaherty · Wayne State University · U10 · FY2008 · CA

Investigating Mechanisms of Hyperprogression on Anti-PD-1 Immunotherapy

$217,163
Andrew B. Sharabi · University Of California, San Diego · R21 · FY2022 · CA

Targeting COPZl in miR-152 deficient tumor cells

$217,117
Michael Shtutman · University Of South Carolina At Columbia · P20 · FY2016 · GM

Statistical Methods for Analyzing Antigen Receptors Data

$217,094
Grzegorz A Rempala · Augusta University · R01 · FY2011 · CA

Role of AhR/Arnt Signaling Pathway in Carcinogenesis

$217,072
Rutgers The St Univ Of Nj New Brunswick · R01 · FY2005 · ES

RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION

$217,066
Marshall University · R01 · FY2000 · CA

TUMOR ASSOCIATED DENDRITIC CELLS

$217,049
University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA